[Erythema multiforme, aplasia, cholestatic hepatitis during treatment with Augmentin (amoxicillin + clavulanic acid)].
Escallier
F
F
Service de Dermatologie, Hôpital du Bocage, Dijon.
Dalac
S
S
Caillot
D
D
Boulitrop
C
C
Collet
E
E
Lambert
D
D
D000368:Aged; D000369:Aged, 80 and over; D000658:Amoxicillin / Q000009:adverse effects*; D019980:Amoxicillin-Potassium Clavulanate Combination; D000741:Anemia, Aplastic / Q000139:chemically induced*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002779:Cholestasis / Q000139:chemically induced; D002969:Clavulanic Acids / Q000009:adverse effects*; D004359:Drug Therapy, Combination / Q000009:adverse effects; D004892:Erythema Multiforme / Q000139:chemically induced*; D006801:Humans; D008297:Male
D002969:Clavulanic Acids; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin
Erythème polymorphe, aplasie, hépatite cholestatique au cours d'un traitement par Augmentin (amoxicilline + acide clavulanique).